NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/09/2024
Back to search
Official data from USPTO
INGENOX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
16
Latest update
07/09/2024
Classification
Registered
Trademark type
Word
Nice classes
5, 42
Filing date
05/26/2023
Registration date
07/09/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/09/2024
Last transaction
07/09/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
Oxford, GB
Examiner
KEATING, MICHAEL
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
INGENOX THERAPEUTICS LIMITED
Representatives
PATRICE P. JEAN HUGHES HUBBARD & REED, LLP
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Epigenetic drugs for the treatmentdiagnosisdetection and/or prevention of cancer; epigenetic drugs targeting arginine methylation in cancer; inhibitors of arginine methylation for the treatment of cancer; inhibitors of protein arginine methyl-transferase (PRMT) for the treatment of cancer; cancer treatment vaccines; therapeutic vaccines for treating cancer; cancer therapy subsection vaccines; compounds for the treatmentdiagnosisdetection and/or prevention of cancer; pharmaceutical productspreparations and substances for the treatmentdiagnosisdetection and/or prevention of cancer; biological preparations and substances for the treatmentdiagnosisdetection and/or prevention of cancer
Class 42
biochemical research and development services; medical research and development services; scientific research and development services; pharmaceutical research and development services; research and development in the field of epigenetic drugs for the treatmentdiagnosisdetection and/or prevention of cancer; research and development in the field of epigenetic drugs targeting arginine methylation in cancer; research and development in the field of inhibitors of arginine methylation for the treatment of cancer; research and development in the field of inhibitors of protein arginine methyl-transferase (PRMT) for the treatment of cancer; research and development in the field of cancer treatment vaccinestherapeutic vaccines for treating cancer and/or cancer therapy subsection vaccines; research and development in the field of compounds for the treatmentdiagnosisdetection and/or prevention of cancer; research and development in the field of pharmaceutical productspreparations and substances for the treatmentdiagnosisdetection and/or prevention of cancer; research and development in the field of biological preparations and substances for the treatmentdiagnosisdetection and/or prevention of cancer; consultancyadvisory and/or information services relating to or connected with the aforementioned services
Publications
History of USPTO decisions and trademark events.
16 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/09/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/23/2024
PUBO
PUBLISHED FOR OPPOSITION
04/23/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/03/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/13/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
03/13/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/13/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
03/13/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/13/2024
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
03/11/2024
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
03/05/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/20/2024
DOCK
ASSIGNED TO EXAMINER
02/20/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/27/2023
NWAP
NEW APPLICATION ENTERED
05/30/2023
Continuous trademark protection
Get notified about every new filing that threatens INGENOX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.